Dr. Chengappa and Dr. Gannon give a joint presentation on discussing specific patient outcomes improvements from the pilot intervention program.
Educational objectives:
Upon completion of this activity, participants should be able to:
- Describe specific patient outcomes improvements from our pilot intervention
- Review predictors of successful anticholinergic burden reduction in patients with schizophrenia
- Analyze barriers to successful anticholinergic burden reduction in patients with schizophrenia
Disclosures:
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation Statement:
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.05) continuing education units (CEU) which are equivalent to .5 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 2/12/2019 | Last Modified On: 2/28/2023 | Expires: 2/28/2024
